Ambria Capital

“Investing in real estate can help expand experiential medicines like ketamine and MDMA for treating PTSD and build infrastructure for upcoming FDA-approved therapies,” said Daniel Carcillo, founder and CEO at Wesana Health Holdings Inc (OTCQB: WSNAF) at Benzinga Psychedelics...

“We are not going to be walking into a dispensary and buying DMT or ayahuasca any time soon,” said Simeon Schnapper, managing partner JLS FUND at Benzinga Psychedelics Capital Conference Thursday in Miami Beach, Florida. Comparing the cannabis and psychedelics...

HealingMaps, an informative psychedelic therapy search site, announced the closing of a seed round funding for a total $1 million coming from eight investors including Phyto Partners and Ambria Capital.  As part of the investment, Ambria Capital and Phyto Partner’s managing partner Cody...

Mike Tyson's cannabis brand Tyson 2.0, closed its oversubscribed $9 milllion series A round led by JW Asset Management. Additional investors in the round include K2, Ambria Capital, Tress Capital, and Patrick Carroll. Tyson 2.0 co-founder, president and chairman, Chad Bronstein stated, "...

Venture capital fund Phyto Partners, LLC, announced today the launch of its fourth private equity fund, called Phyto IV, LP, focused on businesses that operate around neurowellness and brain health, as well as the therapeutic use of psychedelic compounds. For the management of the new fund,...